Anti-CD37 scFv h(CD4-CD3ζ) CART, pCDCAR1

Business Request

United States

"The vector of anti-CD37 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD37. The T cells are genetically modified through transduction with a vector expressing scFv of anti-CD37 antibody linked to a CD4 transmembrane domain and CD3-zeta signaling domains. And the vector product was designed for the treatment of B cell malignancies, such as chronic lymphocytic leukemia (CLL), B cell non-Hodgkin lymphoma (B cell NHL), hairy cell leukemia (HCL), acute lymphoblastic leukemia (ALL) and lymphoplasmacytic lymphoma.
https://www.creative-biolabs.com/car-t/pcdcar1-cd37-h-4%CE%B6-t-139.htm"

"The vector of anti-CD37 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD37. The T cells are genetically modified through transduction with a vector expressing scFv of anti-CD37 antibody linked to a CD4 transmembrane domain and CD3-zeta signaling domains. And the vector product was designed for the treatment of B cell malignancies, such as chronic lymphocytic leukemia (CLL), B cell non-Hodgkin lymphoma (B cell NHL), hairy cell leukemia (HCL), acute lymphoblastic leukemia (ALL) and lymphoplasmacytic lymphoma.
https://www.creative-biolabs.com/car-t/pcdcar1-cd37-h-4%CE%B6-t-139.htm"

[RequestAdvantages]

[RequestComments]

1276

Creative Biolabs